Mylan (MYL) on Watch Negative at Standard & Poor's On Potential Perrigo Deal

Standard & Poor's Ratings Services today placed its ratings on Mylan Inc. (NYSE: MYL), including its 'BBB-' corporate credit rating, on CreditWatch with negative implications, following its announcement that it was in discussions to acquire Perrigo in a roughly $29 billion deal to be funded by a mix of cash, equity, and debt.

A potential acquisition of Perrigo would further strengthen Mylan's business, adding a leading OTC business and a high-margin franchise in Tysabri. Both Perrigo and Mylan are viewed as having "satisfactory" business risk profiles currently.

However, the acquisition could also significantly increase debt leverage. Our current ratings reflect a "significant" financial risk profile, and the potential for improved credit measures. We had expected leverage of 2.2x and funds from operations (FFO) to adjusted debt of about 30% by end of 2015. "To what degree this expectation is disrupted, how quickly the company de-levers, and the company's continued appetite for acquisitions will be significant factors in determining the ultimate rating and outlook," said Standard & Poor's credit analyst Arthur Wong.

We will resolve the CreditWatch placement on Mylan when there is more clarity as to the financing terms of a potential acquisition of Perrigo and the de-levering plans post-acquisition.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• InVitae (NVTA) Enters into Agreement with Labcorp (LH) for Sale of Business
• WWP, Plc (WPP) Issues Q1 Trading Update